67. Polycystic kidney disease Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 251 / Drugs : 278 - (DrugBank : 69) / Drug target genes : 97 - Drug target pathways : 182
| Other names | PKD;PCKD;Polycystic kidney; | ||
|---|---|---|---|
| Disease group | Kidney and urinary diseases | ||
|
Domestic patients
Med expenses recipients, FY2024 (corrected) (in Japanese) |
13,912 patients Age distribution
|
||
| Clinical research form (in Japanese) MHLW Intractable Diseases, FY2026 (in Japanese) | Overview, diagnostic criteria, etc. (pdf), Clinical research form (pdf) 067-01, 067-02 | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 2-17-38. Polycystic kidney disease; PKD | ||
| Sub-diseases (Clinical research forms may not be available for all sub-diseases.) | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 67-1. | Autosomal dominant polycystic kidney disease;Autosomal dominant PKD;ADPKD; | 2-17-38. Polycystic kidney disease; PKD | |
| 67-2. | Autosomal recessive polycystic kidney disease;Autosomal recessive PKD;ARPKD; | 2-17-38. Polycystic kidney disease; PKD | |
